GlobeNewswire by notified

Volta Finance Limited: Net Asset Value as at 31 August 2022

Share

Volta Finance Limited (VTA / VTAS)August2022 monthly report

NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES

*****
Guernsey, 13 September2022

AXA IM has published the Volta Finance Limited (the “Company” or “Volta Finance” or “Volta”) monthly report for August. The full report is attached to this release and will be available on Volta’s website shortly (www.voltafinance.com).

PERFORMANCE and PORTFOLIO ACTIVITY

For the second consecutive month, August saw a recovery from the losses faced in Q2 2022 with the Ukrainian crisis. The fund gained +3.0%, mainly driven by CLO equity holdings.

Through asset classes, the monthly performances** were: +1.5% for Bank Balance Sheet transactions, +4.6% for CLO equity tranches; +3.3% for CLO debt; -0.9% for Cash Corporate Credit and ABS (together representing 2.3% of NAV).

In the footsteps of most markets the loan markets rallied again in August and therefore CLOs followed.

In August, CLO trustee reports are showing again that CLO managers are, on average, able to build some par, reinvesting the few prepayments in loans at discounts. – true for CLOs in RP. When considering risk measures, August was relatively stable but when considering broader credit markets we started seeing more upgrades than downgrades. Some deterioration may come regarding CLO risk metrics in the coming months (higher CCC bucket for example) but we still expect such deterioration to be smooth.

Very near the end of August we saw a few defaults materializing in the US loan market so that last-12-month default rate went from 0.3% at the end of July to 0.6% at the end of August. Knowing that the average annual historical default rate is in the area of 2.8%, we are still, for the time being, in a low default rate environment. At the end of August, the same measure was at 0.7% for European loans.

Our view is still that we may see more defaults materializing next year and we expect a default rates for 2023 to reach something in the area of 2% for the US, 3% for Europe. With this kind of default expectation the projected yield for Volta’s CLO book is slightly above 24% (based on the NAV; from the current share price we have a projected yield above 30%).

The kind of deterioration we expect should not cause any meaningful diversion of cash flows: we expect Volta to receive full coupons from all its positions for the second half of 2022 and for 2023.

In August, Volta received the equivalent of €1.5m in terms of interest and coupons. For the 6 months ended July 2022, Volta received €24.8m interest and coupons representing a 21.1% annualized cash flow to NAV.

During the month, Volta invested in a new CLO Equity in USD and participated in the warehouse attached to this position for a total of €2.7m equivalent. The projected IRR for this CLO Equity, incorporating the associated gain from the warehouse, is in the area of 17% IRR.

For the coming weeks, Volta will participate in one European CLO warehouse with the intention to roll into the CLO equity at issuance. Our investment thesis is to be able to buy European loans at a discount in Q4 2022 at a point in time when we expect to see some pressure on European Loans: we may see some warehouse liquidations at this point (some of the warehouses opened in Q4 2021, that have been unable to transform into a CLO in due time) while the loan market will have to face a poor Q3 earning season.

As at the end of August 2022, Volta’s NAV was €233.9m or €6.39 per share.

*It should be noted that approximately 6.8% of Volta’s GAV comprises investments for which the relevant NAVs as at the month-end date are normally available only after Volta’s NAV has already been published. Volta’s policy is to publish its NAV on as timely a basis as possible to provide shareholders with Volta’s appropriately up-to-date NAV information. Consequently, such investments are valued using the most recently available NAV for each fund or quoted price for such subordinated notes. The most recently available fund NAV or quoted price was 6.4% as at 30 July 2022 and 0.4% as at 30June2022..

** “performances of asset classesare calculated as the Dietz-performance of the assets in each bucket, taking into account the Mark-to-Market of the assets at period ends, payments received from the assets over the period, and ignoring changes in cross-currency rates. Nevertheless, some residual currency effects could impact the aggregate value of the portfolio when aggregating each bucket.

CONTACTS

For the Investment Manager
AXA Investment Managers Paris
Serge Demay
serge.demay@axa-im.com
+33 (0) 1 44 45 84 47

Company Secretary and Administrator
BNP Paribas Securities Services S.C.A, Guernsey Branch
guernsey.bp2s.volta.cosec@bnpparibas.com
+44 (0) 1481 750 853

Corporate Broker
Cenkos Securities plc
Andrew Worne
Daniel Balabanoff
+44 (0) 20 7397 8900

*****
ABOUT VOLTA FINANCE LIMITED

Volta Finance Limited is incorporated in Guernsey under The Companies (Guernsey) Law, 2008 (as amended) and listed on Euronext Amsterdam and the London Stock Exchange's Main Market for listed securities. Volta’s home member state for the purposes of the EU Transparency Directive is the Netherlands. As such, Volta is subject to regulation and supervision by the AFM, being the regulator for financial markets in the Netherlands.

Volta’s investment objectives are to preserve capital across the credit cycle and to provide a stable stream of income to its shareholders through dividends. Volta seeks to attain its investment objectives predominantly through diversified investments in structured finance assets. The assets that the Company may invest in either directly or indirectly include, but are not limited to: corporate credits; sovereign and quasi-sovereign debt; residential mortgage loans; and, automobile loans. The Company’s approach to investment is through vehicles and arrangements that essentially provide leveraged exposure to portfolios of such underlying assets. The Company has appointed AXA Investment Managers Paris an investment management company with a division specialised in structured credit, for the investment management of all its assets.

*****

ABOUT AXA INVESTMENT MANAGERS
AXA Investment Managers (AXA IM) is a multi-expert asset management company within the AXA Group, a global leader in financial protection and wealth management. AXA IM is one of the largest European-based asset managers with 2,460 professionals and €887 billion in assets under management as of the end of December 2021.

*****

This press release is published by AXA Investment Managers Paris (“AXA IM”), in its capacity as alternative investment fund manager (within the meaning of Directive 2011/61/EU, the “AIFM Directive”) of Volta Finance Limited (the "Volta Finance") whose portfolio is managed by AXA IM.

This press release is for information only and does not constitute an invitation or inducement to acquire shares in Volta Finance. Its circulation may be prohibited in certain jurisdictions and no recipient may circulate copies of this document in breach of such limitations or restrictions. This document is not an offer for sale of the securities referred to herein in the United States or to persons who are “U.S. persons” for purposes of Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or otherwise in circumstances where such offer would be restricted by applicable law. Such securities may not be sold in the United States absent registration or an exemption from registration from the Securities Act. Volta Finance does not intend to register any portion of the offer of such securities in the United States or to conduct a public offering of such securities in the United States.

*****

This communication is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (iii) high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”). The securities referred to herein are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents. Past performance cannot be relied on as a guide to future performance.

*****
This press release contains statements that are, or may deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "anticipated", "expects", "intends", "is/are expected", "may", "will" or "should". They include the statements regarding the level of the dividend, the current market context and its impact on the long-term return of Volta Finance's investments. By their nature, forward-looking statements involve risks and uncertainties and readers are cautioned that any such forward-looking statements are not guarantees of future performance. Volta Finance's actual results, portfolio composition and performance may differ materially from the impression created by the forward-looking statements. AXA IM does not undertake any obligation to publicly update or revise forward-looking statements.

Any target information is based on certain assumptions as to future events which may not prove to be realised. Due to the uncertainty surrounding these future events, the targets are not intended to be and should not be regarded as profits or earnings or any other type of forecasts. There can be no assurance that any of these targets will be achieved. In addition, no assurance can be given that the investment objective will be achieved.

The figures provided that relate to past months or years and past performance cannot be relied on as a guide to future performance or construed as a reliable indicator as to future performance. Throughout this review, the citation of specific trades or strategies is intended to illustrate some of the investment methodologies and philosophies of Volta Finance, as implemented by AXA IM. The historical success or AXA IM’s belief in the future success, of any of these trades or strategies is not indicative of, and has no bearing on, future results.

The valuation of financial assets can vary significantly from the prices that the AXA IM could obtain if it sought to liquidate the positions on behalf of the Volta Finance due to market conditions and general economic environment. Such valuations do not constitute a fairness or similar opinion and should not be regarded as such.

Editor: AXA INVESTMENT MANAGERS PARIS, a company incorporated under the laws of France, having its registered office located at Tour Majunga, 6, Place de la Pyramide - 92800 Puteaux. AXA IMP is authorized by the Autorité des Marchés Financiers under registration number GP92008 as an alternative investment fund manager within the meaning of the AIFM Directive.

*****

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Karolinska Developments portföljbolag Umecrine Cognition inleder andra delen av bolagets fas 1b/2-studie i PBC8.5.2024 09:30:46 CEST | Pressemelding

STOCKHOLM, SVERIGE 8 maj 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar att portföljbolaget Umecrine Cognition har randomiserat de första två patienterna till den andra delen av bolagets pågående kliniska fas 1a/2-studie med golexanolon i patienter med primär biliär kolangit, PBC. Top line-resultat beräknas presenteras under det första halvåret 2025. Umecrine Cognition utvecklar en helt ny typ av läkemedel för att lindra kognitiva symtom orsakade av leversjukdomar. Bolagets längst framskridna läkemedelskandidat golexanolon utvärderas för närvarande i en randomiserad, dubbelblind, placebokontrollerad klinisk fas 1b/2-studie i patienter med primär biliär kolangit, PBC, som upplever klinisk signifikant trötthet och kognitiva symtom. Efter klartecken från Umecrine Cognitions interna säkerhetsutvärderingskommitté, iSRC, att fortsätta till den andra delen av studien är målet nu att utvärdera den preliminära effekten av golexanolon samt att fortsätta dokumentera läkemedelsk

Karolinska Development’s portfolio company Umecrine Cognition initiates second part of clinical phase 1a/2 study in PBC8.5.2024 09:30:46 CEST | Press release

STOCKHOLM, SWEDEN – May 8, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has randomized its first two patients to the second part of the ongoing clinical phase 1b/2 study of golexanolone in patients with Primary Biliary Cholangitis, PBC. Top-line results are expected in first half of 2025. Umecrine Cognition is developing a new class of drugs to alleviate cognitive symptoms caused by liver disease. The company's most advanced drug candidate, golexanolone, is currently being evaluated in a randomized, double-blind, placebo-controlled, clinical phase 1b/2 study in patients with primary biliary cholangitis (PBC) who experience clinically significant fatigue and cognitive symptoms. Following recent authorization from Umecrine Cognitions internal safety review committee (iSRC), to proceed to the second part of the study, the aim is now to evaluate the preliminary efficacy of golexanolone, as well as continue the docume

IDEX Biometrics is bringing biometric cards to market with large smart card manufacturer in South Asia8.5.2024 09:30:00 CEST | Press release

Oslo, Norway, 8 May 2024 – IDEX Biometrics and one of the largest smart card manufacturers in South Asia are deploying smart cards across Asia and globally. With over 3 billion cards manufactured to date and a production capacity of 25 million cards monthly, this partner will support IDEX Biometrics continued expansion and growth across Asia Pacific, Middle East, Africa, and the USA. Accredited by Visa, Mastercard and RuPay and with a growing client portfolio of banks, government agencies, telecom companies, transportation authorities, and corporate enterprises, the partner’s strong market position will accelerate go-to-market of biometric payment and access cards. These biometric smart cards, based on IDEX Pay and IDEX Access, are expected to reach the market by the end of 2024. "This is another testament to IDEX Biometrics strategic focus and expansion in Asia," commented Catharina Eklof, Chief Commercial Officer of IDEX Biometrics. "The recognized technology expertise in smart card

Interim Report Q1 20248.5.2024 09:12:21 CEST | Press release

2024 off to a good start with continued revenue growth Revenue growth of 14% in Q1 2024, primarily arising from our key Cloud ERP Business Lines, Dynamics and M3. EBITDA amounted to DKK 55m, corresponding to an EBITDA margin of 12.4%. Excluding a net gain of DKK 20m from settlement of M3CS legal case, the EBITDA margin was 7.9%. Overall, a satisfactory start to the year. “We came off to a good start of the year driven by strong performance in our Cloud ERP business. Our customers’ focus on safeguarding critical business systems is currently reshaping demand, thus underlining the strength of our end-to-end portfolio of services in a wide range of markets,” says CEO & President, Søren Krogh Knudsen Q1 2024 highlights Revenue growth of 14% amounting to DKK 444m. 11% growth adjusted for acquisitions and currency.EBITDA amounted to DKK 55m. DKK 35m adjusted for the M3CS legal case.EBITDA margin was 12.4% compared to 10.0% in Q1 2023. Adjusted for the M3CS legal case, EBITDA margin was 7.9%.

Værdipapirfonden Sparinvest – Offentliggørelse af antal investorer8.5.2024 09:10:32 CEST | pressemeddelelse

Mandag 13. maj 2024 har afdeling INDEX Emerging Market Bonds og andelsklassen INDEX Emerging Market Bonds Akk. – KL A første handelsdag på Nasdaq Copenhagen A/S. ISINAfdelingsnavnAntal investorerAntal udstedte beviserFormue, DKK DK0062729406 INDEX Emerging Market Bonds 62 3.397.791,00 339.779.100,00 DK0062729596 INDEX Emerging Market Bonds Akk. – KL A 40 6.386.977,00 638.697.700,00 Mere information om afdelingerne findes på www.sparinvest.dk. Henvendelser vedrørende nærværende fondsbørsmeddelelse kan rettes til Morten Skipper på npa.jur@nykredit.dk. Med venlig hilsen Værdipapirfonden Sparinvest Morten Skipper Direktør, ID-Sparinvest, Filial af Sparinvest S.A., Luxembourg

HiddenA line styled icon from Orion Icon Library.Eye